ProteinLogic
Pre-clinicalProteinLogic has developed ImmiPrint®, a novel diagnostic technology platform, based on the detection of non-obvious diagnostic patterns in soluble immune proteins in the blood and other body fluids through machine learning. These patterns form unique signatures of disease presence, stage, and potential response to treatment.
About
ProteinLogic has developed ImmiPrint®, a novel diagnostic technology platform, based on the detection of non-obvious diagnostic patterns in soluble immune proteins in the blood and other body fluids through machine learning. These patterns form unique signatures of disease presence, stage, and potential response to treatment.
Funding History
2Total raised: $1.7M
Company Info
Contact
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile